Patents Assigned to CLARIDEI LABORATORIES, INC.
  • Formulations for epidermal repair
    Patent number: 11135184
    Abstract: The present disclosure is directed to dermatological formulations and their use for treating a variety of dermatological diseases and disorders, and for repairing and restoring a disrupted epidermal barrier, inhibiting inflammation, restoring a proper environment for maintaining a balanced symbiotic microbiome, and inhibiting the growth of pathogenic microorganisms in the epidermis—the outer layer of mammalian skin.
    Type: Grant
    Filed: June 14, 2018
    Date of Patent: October 5, 2021
    Assignee: Claridei Laboratories, Inc.
    Inventor: Cheryl Lee Eberting
  • Compositions for the treatment of dermatological diseases and disorders
    Patent number: 10918652
    Abstract: The present disclosure is directed to topical dermatological formulations, dermatological cleansing compositions, and bathwater conditioners designed to acidify the skin, and their use for restoring epidermal acidity, restoring a the epidermal barrier, inhibiting inflammation, establishing an environment appropriate for maintaining a balanced symbiotic microbiome, and inhibiting the growth of pathogenic microorganisms in the epidermis—the outer layer of mammalian skin.
    Type: Grant
    Filed: July 11, 2019
    Date of Patent: February 16, 2021
    Assignee: Claridei Laboratories, Inc.
    Inventor: Cheryl Lee Eberting
  • COMPOSITIONS FOR THE TREATMENT OF DERMATOLOGICAL DISEASES AND DISORDERS
    Publication number: 20190336517
    Abstract: The present disclosure is directed to topical dermatological formulations, dermatological cleansing compositions, and bathwater conditioners designed to acidify the skin, and their use for restoring epidermal acidity, restoring a the epidermal barrier, inhibiting inflammation, establishing an environment appropriate for maintaining a balanced symbiotic microbiome, and inhibiting the growth of pathogenic microorganisms in the epidermis—the outer layer of mammalian skin.
    Type: Application
    Filed: July 11, 2019
    Publication date: November 7, 2019
    Applicant: CLARIDEI LABORATORIES, INC.
    Inventor: Cheryl Lee Eberting